Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study

CONTEXT: The effect of pegvisomant on IGF1 levels in patients with acromegaly is well documented, but little is known of its long-term impact on comorbidity. AIM: The aim of this retrospective study was to evaluate the effects of long-term pegvisomant therapy on cardiorespiratory and metabolic comor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhn, Emmanuelle, Maione, Luigi, Bouchachi, Amir, Rozière, Myriam, Salenave, Sylvie, Brailly-Tabard, Sylvie, Young, Jacques, Kamenicky, Peter, Assayag, Patrick, Chanson, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592912/
https://www.ncbi.nlm.nih.gov/pubmed/26429918
http://dx.doi.org/10.1530/EJE-15-0500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592912/
https://www.ncbi.nlm.nih.gov/pubmed/26429918
http://dx.doi.org/10.1530/EJE-15-0500

Ejemplares similares